相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
Guo-hai Shi et al.
ACTA PHARMACOLOGICA SINICA (2010)
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Zhang Chun-zhi et al.
BMC CANCER (2010)
FoxM1 Mediates Resistance to Herceptin and Paclitaxel
Janai R. Carr et al.
CANCER RESEARCH (2010)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
Liming Zhang et al.
CARCINOGENESIS (2010)
MicroRNA-21: From Cancer to Cardiovascular Disease
Virginija Jazbutyte et al.
CURRENT DRUG TARGETS (2010)
Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
Kun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
Bao Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
Xuan Zhou et al.
LABORATORY INVESTIGATION (2010)
Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB
Erin C. Connolly et al.
MOLECULAR CANCER RESEARCH (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide
Linhua Liu et al.
LIFE SCIENCES (2010)
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Pedro P. Medina et al.
NATURE (2010)
Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs
F. Loayza-Puch et al.
ONCOGENE (2010)
Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells
Mei Mei et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2010)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
Trastuzumab-induced HER Reprogramming in Resistant Breast Carcinoma Cells
Murli Narayan et al.
CANCER RESEARCH (2009)
microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
Peng Wang et al.
CANCER RESEARCH (2009)
BMP-6 inhibits microRNA-21 expression in breast cancer through repressing δEF1 and AP-1
Jun Du et al.
CELL RESEARCH (2009)
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Jinsong Li et al.
CLINICAL CANCER RESEARCH (2009)
Resistance to Trastuzumab in Breast Cancer
Paula R. Pohlmann et al.
CLINICAL CANCER RESEARCH (2009)
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
Jason T. Huse et al.
GENES & DEVELOPMENT (2009)
Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion
Tzu-Hsuan Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hyaluronan-CD44 Interaction with Protein Kinase Cε Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Mitsuo Kato et al.
NATURE CELL BIOLOGY (2009)
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
F. Talotta et al.
ONCOGENE (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
Masahiro Seike et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
Gabriella Mariani et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden Syndrome
Marcus G. Pezzolesi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Carme Camps et al.
CLINICAL CANCER RESEARCH (2008)
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
Jinmai Jiang et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators
Galina Gabriely et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
Zhiyu Zhang et al.
LABORATORY INVESTIGATION (2008)
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
Changchun Xiao et al.
NATURE IMMUNOLOGY (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)
Shuomin Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Differential sensitivities of trastuzumab (Herceptin®)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors
CT Chan et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer
FJ Esteva et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)